Amino acid (AA) sequence of GnRH isoforms. The bolded regions represent the conserved NH3- and COOH- terminal residues. The numbers represent the relative position of each AA in the GnRH peptide (1 represents the N-terminal AA)
1. Introduction
Proper gonadal function in mammals depends on gonadotropins secreted from the pituitary gland in a pulsatile manner. The hypothalamus, in turn, controls the secretion of gonadotropins by the pulsatile secretion of gonadotropin releasing hormone (GnRH) into the portal circulation of the pituitary. The idea of brain control over the hypophysis was first postulated by Geoffrey Harris during the late 1940s and early 1950s (Harris, 1948). The evidence available at that time indicated that stimulation of the central nervous system, but not direct stimulation of the pars distalis or neural lobe, caused the release of adenohypophysial hormones. During the 1950s and 1960s, trophic substances were extracted from the brain of different species (Guillemin, 2005). These releasing factors obtained from the median eminence affected secretions of the pars distalis. The search for these releasing factors was lead by McCann, Schally and Guillemin (Guillemin and Rosenberg, 1955; McCann and Fruit, 1957; Rumsfeld and Porter, 1962; Saffran et al., 1955).
Andrew Schally and his team isolated and synthesized for the first time the decapeptide GnRH, after the extraction of more than 250,000 pig hypothalami (Matsuo et al., 1971; Wade, 1978). Initially Schally and coworkers postulated that one hypothalamic hormone LH-RH/FSH-RH or simply GnRH controls the secretion of both LH and FSH from the pituitary gland (Schally et al., 1971). The terms luteinizing hormone-releasing hormone, and gonadotropin-releasing hormone have been widely adopted, and most journals allow the use of both names and abbreviations (Schally, 2000). In addition to GnRH, the occurrence of other two GnRH isoforms was first reported in chickens more than 10 years after of Dr. Schally’s initial report (King and Millar, 1982; Miyamoto et al., 1982; Miyamoto et al., 1984). To date, several structural variants of GnRH have been identified in diverse vertebrates (Barran et al., 2005; Millar et al., 2004). These isoforms have various functions, including paracrine, autocrine, neuroendocrine, and neurotransmitter/neuromodulatory roles in the central and peripheral nervous systems (King and Millar, 1995; Millar and King, 1987; Sealfon et al., 1997; Skinner et al., 2009).
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | |
Mammal (mGnRH) | ||||||||||
Chicken-I (cGnRH-I) | ||||||||||
Chicken-II (cGnRH-II) | ||||||||||
Lamprey-III (lGnRH-III) |
The nomenclature used to distinguish different GnRH isoforms between mammalian and non-mammalian species have been described using a variety of phylogenic and genomic synteny analyses (Kim et al., 2011; Millar et al., 2004; Roch et al., 2011; Tostivint, 2011). For the purpose of this book chapter, we adopted the nomenclature based on the species in which they were first discovered, depicted in Table 1, and described elsewhere (Millar et al., 2004).
In addition to the classically described mammalian form of GnRH (for extensive review see (Barb et al., 2001; Clarke, 2002; Esbenshade et al., 1990; Kaiser et al., 1997; McCann et al., 2002; Millar, 2005; Millar et al., 2008)), chicken GnRH-II (cGnRH-II) and lamprey GnRH-III (lGnRH-III) are of particular significance because they may coordinate the control of LH and FSH secretion in some vertebrate species.
2. GnRH receptors
The coordination of gonadotropin secretion is also modulated by the interaction of the GnRH peptide with its receptors. The GnRH receptor (GnRHR) has the characteristic feature of a classical seven-transmembrane G-protein-coupled receptor (Millar, 2003, 2005; Neill, 2002). Four vertebrate GnRHR lineages have been proposed using genome synteny and phylogenic analyses; nonmammalian type I, nonmammalian type II, nonmammalian type III/mammalian type II, and mammalian type I (Kim et al., 2011). For the purpose of this book chapter, we refer to the type I and type II GnRHRs as the mammalian type I and mammalian type II GnRH receptor, respectively.
There is evidence that in the rhesus monkey (
In the pig, as well as other mammals, type I GnRHRs are characterized by the absence of a carboxyl-terminal tail (Kakar et al., 1992; Millar et al., 2004; Neill et al., 2004; Tsutsumi et al., 1992; Weesner and Matteri, 1994). The tail-less type I GnRHR is associated with a resistance to rapid desensitization and ligand-induced internalization (Blomenrohr et al., 1999). When COS-1 cells expressing the type I receptor were incubated with a maximal dose of a mGnRH agonist, [3H]-inositol phosphate (IP) accumulated for 90 min indicating the failure of mGnRH desensitization during the experimental period (Neill, 2002). From a practical standpoint, we have demonstrated that administration of mGnRH at different frequencies differentially regulates the concentrations and the expression of the type I GnRHR (Vizcarra et al., 1997). Concentrations and expression of the type I GnRHR were reduced when mGnRH was infused continuously compared with those in control cows (Figure 1). However, when mGnRH was given as a pulse every hour or every fourth hour, concentration and expression of the type I GnRHR were not different from those in control cows. Our data indicates that pulsatile mGnRH does not influence concentrations of the type I GnRHR or type I GnRHR mRNA, but continuous infusion of mGnRH dramatically reduces the concentrations and expression of the type I GnRHR in the pituitary gland (Vizcarra et al., 1997).
The type II GnRHR has only 41% identity with the type I receptor and in contrast to the type I GnRHR, the type II receptor has a C-terminal cytoplasmic tail that is important for cell surface expression and agonist binding. The type II GnRHR has been cloned in several vertebrate species; whereas the type I GnRHR has been identified only in mammals (Kim et al., 2011). The tail of the type II GnRHR is phosphorylated upon agonist-binding followed by internalization and desensitization of the receptor (Blomenrohr et al., 1999). As with the type I receptor, the type II couples to the Gqα protein and, consequently, mediates the intracellular production of inositol trisphosphate (Cabrera-Vera et al., 2003; Millar and Newton, 2010). In contrast to the type I GnRHR, desensitization of the type II GnRHR in rhesus monkeys takes about 60 minutes, reflecting the properties of the cytoplasmic tail (Neill, 2002).
3. Chicken GnRH-II
Phylogenic evidence indicates that cGnRH-II (initially isolated from the chicken brain) is an ancient form of GnRH that has been structurally conserved for over 100 million years of evolution, suggesting that its neural functions may have an important significance (Powell et al., 1994; Rastogi et al., 1998).
In birds, two forms of GnRH (cGnRH-I and cGnRH-II; Table 1) have been reported (King and Millar, 1982; Miyamoto et al., 1982; Miyamoto et al., 1984) and only indirect measurements of the GnRH pulse generator is available by measuring plasma LH concentrations in frequent samples or in pituitary extracts (Chou and Johnson, 1987; Sharp and Gow, 1983; Wilson and Sharp, 1975). In addition, we have reported the episodic nature of gonadotropin secretion in the mature fowl (Vizcarra et al., 2004). Gonadotropin secretion in chickens is characterized by a pulsatile pattern with LH pulses being more frequent and having greater amplitude than FSH pulses (Figure 2). Furthermore, we observed that there was a lack of synchrony between the episodic release of LH and FSH. Only 23% of the LH pulses were associated with FSH episodes, suggesting that in the adult male fowl LH and FSH secretion are regulated independently (Vizcarra et al., 2004).
Both cGnRH-I and -II stimulates gonadotropin release
There is evidence of a behavioral role attributed to cGnRH-II in birds that may be independent from cGnRH-I. Intracerebroventricular (ICV) infusion of cGnRH-II induced copulation solicitation in the female white-crowned sparrow, and social interactions in the house sparrow (
Among primates, the rhesus monkey (
Although human posses a functional cGnRH-II peptide, the type II GnRH receptor is disrupted by a frame shift and premature stop codon (Pawson et al., 2005). The type II GnRHR gene remains active and an alternative splicing (GnRHR-II-reliquum) is expressed in gonadotropes that contains the type I GnRHR (Millar et al., 1999; Pawson et al., 2005). Simultaneous transfection of the type I GnRHR and GnRHR-II-reliquum into COS-7 cells resulted in reduced expression of the type I GnRHR, suggesting a modulator role of the GnRHR-II reliquum on the type I GnRH receptor (Pawson et al., 2005).
In the Musk shrew (
Among domestic animals, the pig is the only relevant livestock species that expresses both a functional mGnRH and cGnRH-II peptide and the associated cognate functional type I and type II GnRHR (Stewart et al., 2009). In bovine and ovine species the cGnRH-II peptide and the type II GnRHR receptor are functionally inactivated (Morgan et al., 2006) and in equine species, the type II GnRHR is functionally inactivated (Stewart et al., 2009).
Very little information on the effect of cGnRH-II on gonadotropin secretion is available in pigs. Treatment of pig pituitary cells with nanomolar concentrations of cGnRH-II consistently stimulated a 15-20 fold increase in LH secretion, while FSH secretion was more variable, ranging from none to a 4-fold stimulation (Neill et al., 2002).
We conducted studies to evaluate the effect of active immunization against cGnRH-II on gonadotropin secretion and testicular function in boars (Bowen et al., 2006). A synthetic cGnRH-II peptide, where the common pGlu-His-Trp-Ser sequence at the N-terminal was suppressed (see table 1) and a Cys residue was incorporated, was used in the conjugation process. Antibody titers were detectable in GnRH-II immunized animals four weeks after primary immunization (bottom panel Figure 5). Titers continued to increase as booster immunizations were given with limited to no cross-reactivity between mGnRH and cGnRH-II. No mGnRH specific antibodies were detected in control animals. Antibody titers against mGnRH were measured to determine if cGnRH-II antibodies recognized mGnRH. None of the animals produced antibodies that recognized mGnRH. However, when a plasma sample from a cow previously immunized against mGnRH was used, antibody titers were significantly higher (Figure 5; inset upper panel). None of the animals produced antibodies that recognized mGnRH, indicating that animals immunized against cGnRH-II produced antibodies that recognized only their own specific amino acid sequence. Active immunization against cGnRH-II significantly decreased gonadotropin secretion when compared with control barrows (Figure 6). These data suggest that the two GnRHs and GnRHRs systems, along with differences in signaling pathways, provide the potential for differential gonadotropin secretion in pigs.
GnRH antagonists, of which thousands have been formulated, cause an immediate and rapid reversible suppression of gonadotropin secretion. The principal mechanism of action of GnRH antagonists is competitive receptor occupancy of GnRHRs (Herbst, 2003; Huirne and Lambalk, 2001). The first generation of mGnRH antagonists contained replacements for His at position 2 and for Trp at position 3 (Huirne and Lambalk, 2001). The inhibitory activity increased after incorporation of a D-amino acid at position 6, but increased histamine-releasing activity resulted in anaphylactic reactions. The third generation antagonists have low histamine-releasing potency by replacing the D-amino acid at position 6 by neutral D-ureidoalkyl amino acids (Huirne and Lambalk, 2001). In pigs a third-generation antagonist (Cetrorelix) has been used in vivo and in vitro (Neill, 2002; Zanella et al., 2000). The ability of cetrorelix to inhibit [3H]-IP accumulation in response to cGnRH-II was evaluated in COS-1 cells that were transfected with the type II GnRHR. Increased concentrations of cGnRH-II in the media resulted in no inhibition of IP, and when cetrorelix was tested for agonist activity with the type II GnRHR, no activity was observed even at large doses (Neill, 2002). These data suggest that cetrorelix is a potent and specific antagonist to the type I GnRH receptor.
Daily intramuscular (i.m.) doses of cetrorelix decreased gonadotropin secretion in intact and castrated boars and gilts (Wise et al., 2000; Zanella et al., 2000; Ziecik et al., 1989). Administration of low doses (5 µg/kg of body weight; BW) of cetrorelix resulted in a decline of LH but had no effect on FSH concentrations, while doses of 10 µg/kg BW of cetrorelix were sufficient to inhibit FSH secretion (Wise et al., 2000; Zanella et al., 2000). Larger doses (20 µg, 50 µg, and 1 mg/kg BW) of cetrorelix also resulted in a significant decrease in LH concentrations with varied responses in FSH secretion (Moran et al., 2002; Wise et al., 2000; Ziecik et al., 1989). The lack of a consistent reduction of FSH secretion in pigs treated with the type I GnRHR antagonist may be associated with the presence of two GnRHs and two GnRH receptors, together with the differences in their signaling in swine species.
Antagonist for the type II GnRHR have also been developed and tested in cells expressing rat GnRH (Maiti et al., 2003), human endometrial cells (Fister et al., 2007), and mice (Kim et al., 2009). However, all of these species have lost a functional type II GnRHR (Stewart et al., 2009) and data from these experiments are questionable. A type II GnRHR knockdown swine is being developed (Desaulniers et al., 2011). This animal model may provide new cues on the relative contribution of the type II GnRHR in pigs.
Taken together, GnRH-II is the most ancient and conserved member of the GnRH family, it is expressed in several vertebrates, and has the ability to control gonadotropin secretion in species that have a functional GnRH-II and type II GnRHR.
4. Lamprey GnRH-III
Sower and coworkers (Sower et al., 1993), reported the isolation of lGnRH-III from the sea lamprey (
The physiologic role played by lGnRH-III on gonadotropin secretion in mammalian species is controversial. Although lGnRH-III is a weak GnRH agonist, early research in mammalian species suggested that lGnRH-III can selectively stimulate the secretion of FSH without changing concentration of LH.
In rodents, lGnRH-III significantly increased FSH concentrations in a dose-dependent manner when using anterior pituitaries at 10-9 to 10-4
The presence of lGnRH-III in the brain of rats was identified by immunocytochemistry (Dees et al., 1999), and subsequently localized in the dorsomedial preoptic area (POA) of the brain and colocalized with mGnRH (Hiney et al., 2002). However, lGnRH-III was not detected in rats and other rodents by reverse-phase-HPLC followed by RIA, or by performing two successive HPLC steps to prevent the coelution of GnRH peptides (Gautron et al., 2005; Montaner et al., 1999; Montaner et al., 2001). When rats were infused (i.v.) with doses of lGnRH-III or mGnRH, gonadotropin secretion was increased in a dose-dependent manner with a greater increase in LH than FSH concentrations. The potency of lGnRH-III was 180 to 650 fold weaker than that of mGnRH (Kovacs et al., 2002). Similarly, when rat pituitary cells were perfused with lGnRH-III or mGnRH (10-9 to 10-6
Undoubtedly, more research is needed to clarify the existence of lGnRH-III or a FSHRF that may be involved in the differential secretion of gonadotropins in mammals. In addition to the information provided above, other areas of investigation have stressed the need to reconsider the traditional conjecture that a single GnRH molecule controls reproduction (Igarashi and McCann, 1964; McCann et al., 1983; Padmanabhan and McNeilly, 2001). Briefly, lesions to the median eminence (ME) of castrated male rats suppressed LH but not FSH pulses, while animals with posterior to mid-ME lesions had no FSH pulses but maintained LH episodic releases (Marubayashi et al., 1999). Similarly, ablation of the dorsal anterior hypothalamus of ovariectomized rats suppressed FSH pulses but not LH (Lumpkin et al., 1989). These results raise the possibility that another form of GnRH may contribute nontraditionally to the control of reproductive function or may take part in an important neuroendocrine role. The nature of episodic FSH secretion in portal blood cannot be accounted completely by changes in GnRH secretion (Padmanabhan et al., 1997). When male rats were administered GnRH antiserum and/or GnRH antagonists, pulsatile FSH release was maintained while LH was abolished, giving further credence to the view that reproductive function may be regulated by more than one GnRH neuronal system (Culler and Negro-Vilar, 1987). We have observed that GnRH pulse frequency and amplitude differentially regulates LH and FSH gene transcription and serum concentrations of LH and FSH in cattle (Vizcarra et al., 1997). However, this mechanism of FSH secretion does not preclude the existence of other GnRH releasing factors. It is also possible that the concerted action of local pituitary factors and peripheral steroids could lead to a pulsatile FSH pattern. For instance activins, inhibins, and follistatins may provide an autocrine-paracrine regulation of FSH release at the pituitary level (Baird et al., 1991; DePaolo et al., 1991; Mather et al., 1992; Nett et al., 2002; Padmanabhan et al., 2002; Padmanabhan et al., 1997; Padmanabhan and McNeilly, 2001).
Data obtained in the late 1990’s, using the rat model, inspired other laboratories to investigate the use of lGnRH-III in domestic species. Since this peptide was able to selectively stimulate FSH secretion in rats, several researches evaluated the potential use of lGnRH-III in different livestock species. Using similar techniques as those reported in rats, lGnRH-III (or a closely related peptide), was also extracted from sheep stalk-median eminence using a Sephadex G-25 column (Lumpkin et al., 1987; Yu et al., 2000), and from bovine brain samples using HPLC (Yahalom et al., 1999). However, as noted above, the gene expression of lGnRH-III has not been reported in mammalian species. The ability of lGnRH-III (obtained from bovine midbrain tissue) to release LH was evaluated in cultured rat pituitary cells. The potency of lGnRH-III was only about 2% of that of mGnRH, suggesting that lGnRH-III is a weak agonist of mGnRH (Yahalom et al., 1999). When lGnRH-III (0.25 and 0.5 mg) was infused (i.v.) during the luteal phase of the estrous cycle of crossbred heifers, FSH concentrations were increased without changes in LH concentrations. At higher doses (2.0 and 8.0 mg) both FSH and LH were increased compared with basal concentrations. In contrast, a dose of 0.5 mg of lGnRH-III elicited a significant increase in LH with no changes in FSH secretion at day 20 of the estrous cycle. Authors suggested that the selectivity of lGnRH-III in cattle depends on the dosage and the stage of the estrous cycle (Dees et al., 2001).
In sharp contrast to the observations described above, no differential gonadotropin secretion was reported in ovariectomized cows (exposed to different steroid replacement therapy) when infused with doses (0.055, to 1.1 mg/kg BW) of lGnRH-III. Higher doses (4.4 mg/kg BW) released LH but not FSH. Similarly,
A clear and unbiased interpretation of the discordant results observed in cattle (Amstalden et al., 2004; Dees et al., 2001) is difficult. Reagents (RIAs) used in both laboratories to evaluate LH and FSH were provided by the National Hormone and Pituitary Program. Thus, it is unlikely that differences can be attributed to the ability of a particular RIA to detect FSH concentrations (Amstalden et al., 2004). The ovariectomized cow model, with estradiol and progesterone replacement therapy, used in one experiment (Amstalden et al., 2004) may provide a better animal model compared with intact cows. As noted above, it is well established that ovarian follicular peptides such as actvin, inhibin and follistain regulate FSH secretion; therefore, intact animals could be influenced by ovarian secretions that may act as a confounding factor.
Along the same lines described for rats and cattle, there is contradictory evidence on the involvement of lGnRH-III on gonadotropin secretion in pigs. Infusion (i.m.) of lGnRH-III in barrows differentially stimulated FSH secretion within 1 h after treatment (Kauffold et al., 2005). On the other hand, when boars were actively immunized against lGnRH-III, concentrations of both LH and FSH were decreased without any evidence of a differential regulation of gonadotropin secretion (Bowen et al., 2006). We (Barretero-Hernandez et al., 2010) also evaluated the effect of infusion (i.v.) of different doses of lGnRH-III on the release of LH and FSH in pigs. Barrows were used to evaluate the effect of 0.1, 1.0 or 10.0 µg/kg BW of exogenous lGnRH-III on LH and FSH secretion (Figure 7). Blood samples were taken at 10-min intervals for 6 h, starting 2 h before treatments were applied. Relative concentrations of FSH after lGnRH-III infusion did not influence mean concentration of FSH at any of the doses; however, 10.0 µg/kg BW had a significant effect on LH secretion. We conclude that lGnRH-III is a weak GnRH agonist, and at high doses, lGnRH-III has the ability to release LH but not FSH in barrows. Similar findings were also obtained in gilts that were infused (i.m.) with a synthetic lGnRH-III product (Brussow et al., 2010).
Taken together, the gene expression of lGnRH-III and its receptor has not been reported in mammalian species. Although early work in rats, cows and pigs suggested a selective release of FSH via lGnRH-III, the bulk of the evidence does not support a contribution of lGnRH-III on the selective release of FSH. It is possible that a different peptide (closely related to lGnRH-III) may be associated with FSH release.
References
- 1.
Amstalden M. Zieba D. A. Garcia M. R. Stanko R. L. Welsh T. H. Jr Hansel W. H. Williams G. L. 2004 Evidence that lamprey GnRH-III does not release FSH selectively in cattle. Reproduction127 35 43 . - 2.
Baird D. T. Campbell B. K. Mann G. E. Mc Neilly A. S. 1991 Inhibin and oestradiol in the control of FSH secretion in the sheep. Journal of Reproduction and Fertility43 125 138 . - 3.
Barb C. R. Kraeling R. R. Rampacek G. B. 2001 Nutritional regulators of the hypothalamic-pituitary axis in pigs. Reproduction (Cambridge, England) Supplement58 1 15 . - 4.
Barran P. E. Roeske R. W. Pawson A. J. Sellar R. Bowers M. T. Morgan K. Lu Z. L. Tsuda M. Kusakabe T. Millar R. P. 2005 Evolution of constrained gonadotropin-releasing hormone ligand conformation and receptor selectivity. J Biol Chem280 38569 38575 . - 5.
Barretero-Hernandez R. Vizcarra J. A. Bowen A. Galyean M. 2010 Lamprey GnRH-III releases luteinizing hormone but not follicle stimulating hormone in pigs. Reproduction in Domestic Animals45 983 987 . - 6.
Blomenrohr M. Heding A. Sellar R. Leurs R. Bogerd J. Eidne K. A. Willars G. B. 1999 Pivotal role for the cytoplasmic carboxyl-terminal tail of a nonmammalian gonadotropin-releasing hormone receptor in cell surface expression, ligand binding, and receptor phosphorylation and internalization. Molecular Pharmacology56 1229 1237 . - 7.
Bowen A. Khan S. Berghman L. Kirby J. D. Wettemann R. P. Vizcarra J. A. 2006 Immunization of pigs against chicken gonadotropin-releasing hormone-II and lamprey gonadotropin-releasing hormone-III: effects on gonadotropin secretion and testicular function. Journal of Animal Science84 2990 2999 . - 8.
Brussow K. P. Schneider F. Tuchscherer A. Kanitz W. 2010 Influence of synthetic lamprey GnRH-III on gonadotropin release and steroid hormone levels in gilts. Theriogenology74 1570 1578 . - 9.
Cabrera-Vera T. M. Vanhauwe J. Thomas T. O. Medkova M. Preininger A. Mazzoni M. R. Hamm H. E. 2003 Insights into G protein structure, function, and regulation. Endocrine Reviews24 765 781 . - 10.
Chou H. F. Johnson A. L. 1987 Luteinizing hormone secretion from anterior pituitary cells of the cockerel: evidence for an ultradian rhythm. Poultry Science66 732 740 . - 11.
Clarke I. 2002 2002. Two decades of measuring GnRH secretion. Reproduction (Cambridge, England) Supplement59 1 13 . - 12.
Culler M. D. Negro-Vilar A. 1987 Pulsatile follicle-stimulating hormone secretion is independent of luteinizing hormone-releasing hormone (LHRH): pulsatile replacement of LHRH bioactivity in LHRH-immunoneutralized rats. Endocrinology120 2011 2021 . - 13.
Dees W. L. Hiney J. K. Sower S. A. Yu W. H. Mc Cann S. M. 1999 Localization of immunoreactive lamprey gonadotropin-releasing hormone in the rat brain. Peptides20 1503 1511 . - 14.
Dees W. L. Dearth R. K. Hooper R. N. Brinsko S. P. Romano J. E. Rahe H. Yu W. H. Mc Cann S. M. 2001 Lamprey gonadotropin-releasing hormone-III selectively releases follicle stimulating hormone in the bovine. Domest Anim Endocrinol20 279 288 . - 15.
Dellovade T. L. King J. A. Millar R. P. Rissman E. F. 1993 Presence and differential distribution of distinct forms of immunoreactive gonadotropin-releasing hormone in the musk shrew brain. Neuroendocrinology58 166 177 . - 16.
Densmore V. S. Urbanski H. F. 2003 Relative effect of gonadotropin-releasing hormone (GnRH)-I and GnRH-II on gonadotropin release. The Journal of Clinical Endocrinology and Metabolism88 2126 2134 . - 17.
Densmore V. Urbanski H. 2004 Effect of 17beta-estradiol on hypothalamic GnRH-II gene expression in the female rhesus macaque. Journal of Molecular Endocrinology33 145 153 . - 18.
De Paolo L. V. Bicsak T. A. Erickson G. F. Shimasaki S. Ling N. 1991 Follistatin and activin: a potential intrinsic regulatory system within diverse tissues. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine New York, N.Y198 500 512 . - 19.
Desaulniers A. T. Voss A. M. Cederberg R. A. Lee C. Mills G. A. Snyder M. D. White B. R. 2011 6 Production of gonadotropin-releasing hormone II receptor knockdown swine. Reproduction, Fertility and Development24 114 114 . - 20.
El Majdoubi M. Sahu A. Plant T. M. 1998 Effect of estrogen on hypothalamic transforming growth factor alpha and gonadotropin-releasing hormone gene expression in the female rhesus monkey. Neuroendocrinology67 228 235 . - 21.
Esbenshade K. L. Ziecik A. J. Britt J. H. 1990 Regulation and action of gonadotrophins in pigs. Journal of Reproduction and Fertility40 19 32 . - 22.
Fister S. Gunthert A. R. Emons G. Grundker C. 2007 Gonadotropin-releasing hormone type II antagonists induce apoptotic cell death in human endometrial and ovarian cancer cells in vitro and in vivo. Cancer Research67 1750 1756 . - 23.
Gautron J. P. Gras C. Enjalbert A. 2005 Molecular polymorphism of native gonadotropin-releasing hormone (GnRH) is restricted to mammalian GnRH and [hydroxyproline9] GnRH in the developing rat brain. Neuroendocrinology81 69 86 . - 24.
Guillemin R. Rosenberg B. 1955 Humoral hypothalamic control of anterior pituitary: a study with combined tissue cultures. Endocrinology57 599 607 . - 25.
Guillemin, 2005 2005. Hypothalamic hormones a.k.a. hypothalamic releasing factors. J Endocrinol184 11 28 . - 26.
Harris G. 1948 1948. Neural control of the pituitary gland. Physiological Reviews28 139 179 . - 27.
Hattori A. Ishii S. Wada M. 1986 Effects of two kinds of chicken luteinizing hormone-releasing hormone (LH-RH), mammalian LH-RH and its analogs on the release of LH and FSH in Japanese quail and chicken. Gen Comp Endocrinol64 446 455 . - 28.
Herbst K. 2003 2003. Gonadotropin-releasing hormone antagonists. Current Opinion in Pharmacology3 660 666 . - 29.
Heredi-Szabo K. Murphy R. F. Lovas S. 2006 Is lGnRH-III the most potent GnRH analog containing only natural amino acids that specifically inhibits the growth of human breast cancer cells? Journal of Peptide Science.12 714 720 . - 30.
Hiney J. K. Sower S. A. Yu W. H. Mc Cann S. M. Dees W. L. 2002 Gonadotropin-releasing hormone neurons in the preoptic-hypothalamic region of the rat contain lamprey gonadotropin-releasing hormone III, mammalian luteinizing hormone-releasing hormone, or both peptides. Proceedings of the National Academy of Sciences of the United States of America99 2386 2391 . - 31.
Huirne J. A. Lambalk C. B. 2001 Gonadotropin-releasing-hormone-receptor antagonists. Lancet358 1793 1803 . - 32.
Igarashi M. Mc Cann S. M. 1964 A Hypothalamic Follicle Stimulating Hormone-Releasing Factor. Endocrinology74 446 452 . - 33.
Ikemoto T. Park M. K. 2006 Comparative genomics of the endocrine systems in humans and chimpanzees with special reference to GNRH2 and UCN2 and their receptors. Genomics87 459 462 . - 34.
Kaiser U. B. Conn P. M. Chin W. W. 1997 Studies of gonadotropin-releasing hormone (GnRH) action using GnRH receptor-expressing pituitary cell lines. Endocrine Reviews18 46 70 . - 35.
Kakar S. S. Musgrove L. C. Devor D. C. Sellers J. C. Neill J. D. 1992 Cloning, sequencing, and expression of human gonadotropin releasing hormone (GnRH) receptor. Biochem Biophys Res Commun189 289 295 . - 36.
Katz I. A. Millar R. P. King J. A. 1990 Differential regional distribution and release of two forms of gonadotropin-releasing hormone in the chicken brain. Peptides11 443 450 . - 37.
Kauffman A. S. Rissman E. F. 2004a A critical role for the evolutionarily conserved gonadotropin-releasing hormone II: mediation of energy status and female sexual behavior. Endocrinology145 3639 3646 . - 38.
Kauffman A. S. Rissman E. F. 2004b The evolutionarily conserved gonadotropin-releasing hormone II modifies food intake. Endocrinology145 686 691 . - 39.
Kauffman A. S. Wills A. Millar R. P. Rissman E. F. 2005 Evidence that the type-2 gonadotrophin-releasing hormone (GnRH) receptor mediates the behavioural effects of GnRH-II on feeding and reproduction in musk shrews. Journal of Neuroendocrinology17 489 497 . - 40.
Kauffman A. S. Bojkowska K. Wills A. Rissman E. F. 2006 Gonadotropin-releasing hormone-II messenger ribonucleic acid and protein content in the mammalian brain are modulated by food intake. Endocrinology147 5069 5077 . - 41.
Kauffold J. Schneider F. Zaremba W. Brussow K. P. 2005 Lamprey GnRH-III stimulates FSH secretion in barrows. Reproduction in Domestic Animals40 475 479 . - 42.
Kim D. K. Yang J. S. Maiti K. Hwang J. I. Kim K. Seen D. Ahn Y. Lee C. Kang B. C. Kwon H. B. Cheon J. Seong J. Y. 2009 A gonadotropin-releasing hormone-II antagonist induces autophagy of prostate cancer cells. Cancer Research69 923 931 . - 43.
Kim D. K. Cho E. B. Moon M. J. Park S. Hwang J. I. Kah O. Sower S. A. Vaudry H. Seong J. Y. 2011 Revisiting the evolution of gonadotropin-releasing hormones and their receptors in vertebrates: secrets hidden in genomes. Gen Comp Endocrinol170 68 78 . - 44.
King J. A. Millar R. P. 1982 Structure of chicken hypothalamic luteinizing hormone-releasing hormone. II. Isolation and characterization. J Biol Chem257 10729 10732 . - 45.
King J. A. Millar R. P. 1995 Evolutionary aspects of gonadotropin-releasing hormone and its receptor. Cell Mol Neurobiol15 5 23 . - 46.
Kovacs M. Seprodi J. Koppan M. Horvath J. E. Vincze B. Teplan I. Flerko B. 2002 Lamprey gonadotropin hormone-releasing hormone-III has no selective follicle-stimulating hormone-releasing effect in rats. Journal of Neuroendocrinology14 647 655 . - 47.
Krishnan K. A. Proudman J. A. Bolt D. J. Bahr J. M. 1993 Development of an homologous radioimmunoassay for chicken follicle-stimulating hormone and measurement of plasma FSH during the ovulatory cycle. Comp Biochem Physiol Comp Physiol105 729 734 . - 48.
Latimer V. S. Kohama S. G. Garyfallou V. T. Urbanski H. F. 2001 A developmental increase in the expression of messenger ribonucleic acid encoding a second form of gonadotropin-releasing hormone in the rhesus macaque hypothalamus. The Journal of Clinical Endocrinology and Metabolism86 324 329 . - 49.
Lescheid D. W. Terasawa E. Abler L. A. Urbanski H. F. Warby C. M. Millar R. P. Sherwood N. M. 1997 A second form of gonadotropin-releasing hormone (GnRH) with characteristics of chicken GnRH-II is present in the primate brain. Endocrinology138 5618 5629 . - 50.
Lovas S. Palyi I. Vincze B. Horvath J. Kovacs M. Mezo I. Toth G. Teplan I. Murphy R. F. 1998 Direct anticancer activity of gonadotropin-releasing hormone-III. J Pept Res52 384 389 . - 51.
Lumpkin M. D. Moltz J. H. Yu W. H. Samson W. K. Mc Cann S. M. 1987 Purification of FSH-releasing factor: its dissimilarity from LHRH of mammalian, avian, and piscian origin. Brain Research Bulletin18 175 178 . - 52.
Lumpkin M. D. Mc Donald J. K. Samson W. K. Mc Cann S. M. 1989 Destruction of the dorsal anterior hypothalamic region suppresses pulsatile release of follicle stimulating hormone but not luteinizing hormone. Neuroendocrinology50 229 235 . - 53.
Maiti K. Li J. H. Wang A. F. Acharjee S. Kim W. P. Im W. B. Kwon H. B. Seong J. Y. 2003 GnRH-II analogs for selective activation and inhibition of non-mammalian and type-II mammalian GnRH receptors. Molecules and Cells16 173 179 . - 54.
Maney D. L. Richardson R. D. Wingfield J. C. 1997 Central administration of chicken gonadotropin-releasing hormone-II enhances courtship behavior in a female sparrow. Hormones and Behavior32 11 18 . - 55.
Marubayashi U. Yu W. H. Mc Cann S. M. 1999 Median eminence lesions reveal separate hypothalamic control of pulsatile follicle-stimulating hormone and luteinizing hormone release. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. New York, N.Y220 139 146 . - 56.
Mather J. P. Woodruff T. K. Krummen L. A. 1992 Paracrine regulation of reproductive function by inhibin and activin. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. New York, N.Y201 1 15 . - 57.
Matsuo H. Baba Y. Nair R. M. Arimura A. Schally A. V. 1971 Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence. Biochem Biophys Res Commun43 1334 1339 . - 58.
Mc Cann S. M. Fruit A. 1957 Effect of synthetic vasopressin on release of adrenocorticotrophin in rats with hypothalamic lesions. Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine. New York, N.Y96 566 567 . - 59.
Mc Cann S. M. Mizunuma H. Samson W. K. Lumpkin M. D. 1983 Differential hypothalamic control of FSH secretion: a review. Psychoneuroendocrinology8 299 308 . - 60.
Mc Cann S. M. Karanth S. Mastronardi C. A. Dees W. L. Childs G. Miller B. Sower S. Yu W. H. 2001 Control of Gonadotropin Secretion by Follicle-Stimulating Hormone-Releasing Factor, Luteinizing Hormone-Releasing Hormone, and Leptin. Archives of Medical Research32 476 485 . - 61.
Mc Cann S. M. Yu W. H. 2001 FSH-releasing peptides. US Patent 6,300,471. - 62.
Mc Cann S. M. Karanth S. Mastronardi C. A. Dees W. L. Childs G. Miller B. Sower S. Yu W. H. 2002 Hypothalamic control of gonadotropin secretion. Progress in Brain Research141 151 164 . - 63.
Meddle S. L. Bush S. Sharp P. J. Millar R. P. Wingfield J. C. 2006 Hypothalamic pro-GnRH-GAP, GnRH-I and GnRH-II during the onset of photorefractoriness in the white-crowned sparrow (Zonotrichia leucophrys gambelii). Journal of Neuroendocrinology18 217 226 . - 64.
Mezo I. Lovas S. Palyi I. Vincze B. Kalnay A. Turi G. Vadasz Z. Seprodi J. Idei M. Toth G. Gulyas E. Otvos F. Mak M. Horvath J. E. Teplan I. Murphy R. F. 1997 Synthesis of gonadotropin-releasing hormone III analogs. Structure-antitumor activity relationships. Journal of Medicinal Chemistry40 3353 3358 . - 65.
Millar R. P. King J. A. 1987 Structural and functional evolution of gonadotropin-releasing hormone. International Review of Cytology106 149 182 . - 66.
Millar R. Conklin D. Lofton-Day C. Hutchinson E. Troskie B. Illing N. Sealfon S. C. Hapgood J. 1999 A novel human GnRH receptor homolog gene: abundant and wide tissue distribution of the antisense transcript. J Endocrinol162 117 126 . - 67.
Millar R. Lowe S. Conklin D. Pawson A. Maudsley S. Troskie B. Ott T. Millar M. Lincoln G. Sellar R. Faurholm B. Scobie G. Kuestner R. Terasawa E. Katz A. 2001 A novel mammalian receptor for the evolutionarily conserved type II GnRH. Proceedings of the National Academy of Sciences of the United States of America98 9636 9641 . - 68.
Millar R. 2003 GnRH II and type II GnRH receptors. Trends in Endocrinology and Metabolism: TEM 14: 35-43. - 69.
Millar R. P. Lu Z. L. Pawson A. J. Flanagan C. A. Morgan K. Maudsley S. R. 2004 Gonadotropin-releasing hormone receptors. Endocrine Reviews25 235 275 . - 70.
Millar R. 2005 GnRHs and GnRH receptors. Anim Reprod Sci 88: 5-28. - 71.
Millar R. P. Pawson A. J. Morgan K. Rissman E. F. Lu Z. L. 2008 Diversity of actions of GnRHs mediated by ligand-induced selective signaling. Frontiers in Neuroendocrinology29 17 35 . - 72.
Millar R. P. Newton C. L. 2010 The year in G protein-coupled receptor research. Molecular Endocrinology Baltimore, Md24 261 274 . - 73.
Miyamoto K. Hasegawa Y. Minegishi T. Nomura M. Takahashi Y. Igarashi M. Kangawa K. Matsuo H. 1982 Isolation and characterization of chicken hypothalamic luteinizing hormone-releasing hormone. Biochem Biophys Res Commun107 820 827 . - 74.
Miyamoto K. Hasegawa Y. Nomura M. Igarashi M. Kangawa K. Matsuo H. 1984 Identification of the second gonadotropin-releasing hormone in chicken hypothalamus: evidence that gonadotropin secretion is probably controlled by two distinct gonadotropin-releasing hormones in avian species. Proceedings of the National Academy of Sciences of the United States of America81 3874 3878 . - 75.
Montaner A. D. Affanni J. M. King J. A. Bianchini J. J. Tonarelli G. Somoza G. M. 1999 Differential distribution of gonadotropin-releasing hormone variants in the brain of Hydrochaeris hydrochaeris (Mammalia, Rodentia). Cell Mol Neurobiol19 635 651 . - 76.
Montaner A. D. Mongiat L. Lux-Lantos V. A. Park M. K. Fischer W. H. Craig A. G. Rivier J. E. Lescheid D. Lovejoy D. Libertun C. Sherwood N. M. Somoza G. M. 2001 Structure and biological activity of gonadotropin-releasing hormone isoforms isolated from rat and hamster brains. Neuroendocrinology74 202 212 . - 77.
Moran F. M. Ford J. J. Corbin C. J. Mapes S. M. Njar V. C. Brodie A. M. Conley A. J. 2002 Regulation of microsomal450 redox partner proteins, and steroidogenesis in the developing testes of the neonatal pig. Endocrinology 143: 3361-3369. - 78.
Morgan K. Sellar R. Pawson A. J. Lu Z. L. Millar R. P. 2006 Bovine and ovine gonadotropin-releasing hormone (GnRH)-II ligand precursors and type II GnRH receptor genes are functionally inactivated. Endocrinology147 5041 5051 . - 79.
Neill J. 2002 2002. GnRH and GnRH receptor genes in the human genome. Endocrinology143 737 743 . - 80.
Neill J. D. Duck L. W. Musgrove L. C. 2002 Potential regulatory role for GnRH II in gonadotropin secretion: molecular characterization of a GnRH II receptor from pig pituitary. Proceedings of the Society for Neuroscience Abstract 74.9. - 81.
Neill J. D. Musgrove L. C. Duck L. W. 2004 Newly recognized GnRH receptors: function and relative role. Trends in Endocrinology and Metabolism: TEM15 383 392 . - 82.
Nett T. M. Turzillo A. M. Baratta M. Rispoli L. A. 2002 Pituitary effects of steroid hormones on secretion of follicle-stimulating hormone and luteinizing hormone. Domest Anim Endocrinol23 33 42 . - 83.
Okada Y. Murota-Kawano A. Kakar S. S. Winters S. J. 2003 Evidence that gonadotropin-releasing hormone (GnRH) II stimulates luteinizing hormone and follicle-stimulating hormone secretion from monkey pituitary cultures by activating the GnRH I receptor. Biology of Reproduction69 1356 1361 . - 84.
Padmanabhan V. Mc Fadden K. Mauger D. T. Karsch F. J. Midgley A. R. Jr 1997 Neuroendocrine control of follicle-stimulating hormone (FSH) secretion. I. Direct evidence for separate episodic and basal components of FSH secretion. Endocrinology138 424 432 . - 85.
Padmanabhan V. Mc Neilly A. S. 2001 Is there an FSH-releasing factor? Reproduction121 21 30 . - 86.
Padmanabhan V. Karsch F. J. Lee J. S. 2002 Hypothalamic, pituitary and gonadal regulation of FSH. Reproduction (Cambridge, England) Supplement59 67 82 . - 87.
Palyi I. Vincze B. Lovas S. Mezo I. Pato J. Kalnay A. Turi G. Gaal D. Mihalik R. Peter I. Teplan I. Murphy R. F. 1999 Gonadotropin-releasing hormone analogue conjugates with strong selective antitumor activity. Proceedings of the National Academy of Sciences of the United States of America96 2361 2366 . - 88.
Pawson A. J. Maudsley S. Morgan K. Davidson L. Naor Z. Millar R. P. 2005 Inhibition of human type i gonadotropin-releasing hormone receptor (GnRHR) function by expression of a human type II GnRHR gene fragment. Endocrinology146 2639 2649 . - 89.
Perfito N. Zann R. Ubuka T. Bentley G. Hau M. 2011 Potential roles for GNIH and GNRH-II in reproductive axis regulation of an opportunistically breeding songbird. Gen Comp Endocrinol173 20 26 . - 90.
Powell J. F. Zohar Y. Elizur A. Park M. Fischer W. H. Craig A. G. Rivier J. E. Lovejoy D. A. Sherwood N. M. 1994 Three forms of gonadotropin-releasing hormone characterized from brains of one species. Proceedings of the National Academy of Sciences of the United States of America91 12081 12085 . - 91.
Rastogi R. K. Meyer D. L. Pinelli C. Fiorentino M. D’Aniello B. 1998 Comparative analysis of GnRH neuronal systems in the amphibian brain. Gen Comp Endocrinol112 330 345 . - 92.
Rissman E. F. Li X. 1998 Sex differences in mammalian and chicken-II gonadotropin-releasing hormone immunoreactivity in musk shrew brain. Gen Comp Endocrinol112 346 355 . - 93.
Roch G. J. Busby E. R. Sherwood N. M. 2011 Evolution of GnRH: diving deeper. Gen Comp Endocrinol171 1 16 . - 94.
Rumsfeld H. W. Jr Porter J. C. 1962 ACTH-releasing activity of bovine posterior pituitaries. Endocrinology70 62 67 . - 95.
Saffran M. Schally A. V. Benfey B. G. 1955 Stimulation of the release of corticotropin from the adenohypophysis by a neurohypophysial factor. Endocrinology57 439 444 . - 96.
Schally A. V. Arimura A. Kastin A. J. Matsuo H. Baba Y. Redding T. W. Nair R. M. Debeljuk L. White W. F. 1971 Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones. Science173 1036 1038 . - 97.
Schally A. 2000 Use of GnRH in preference to LH-RH terminology in scientific papers. Human Reproduction 15: 2059-2061. - 98.
Schally A. V. Comaru-Schally A. M. Nagy A. Kovacs M. Szepeshazi K. Plonowski A. Varga J. L. Halmos G. 2001 Hypothalamic hormones and cancer. Frontiers in neuroendocrinology22 248 291 . - 99.
Sealfon S. C. Weinstein H. Millar R. P. 1997 Molecular mechanisms of ligand interaction with the gonadotropin-releasing hormone receptor. Endocrine Reviews18 180 205 . - 100.
Sharp P. J. Gow C. B. 1983 Neuroendocrine control of reproduction in the cockerel. Poultry Science62 1671 1675 . - 101.
Sharp P. J. Talbot R. T. Main G. M. Dunn I. C. Fraser H. M. Huskisson N. S. 1990 Physiological roles of chicken LHRH-I and-II in the control of gonadotrophin release in the domestic chicken. J Endocrinol124 291 299 . - 102.
Silver M. R. Nucci N. V. Root A. R. Reed K. L. Sower S. A. 2005 Cloning and characterization of a functional type II gonadotropin-releasing hormone receptor with a lengthy carboxy-terminal tail from an ancestral vertebrate, the sea lamprey. Endocrinology146 3351 3361 . - 103.
Silver M. R. Sower S. A. 2006 Functional characterization and kinetic studies of an ancestral lamprey GnRH-III selective type II GnRH receptor from the sea lamprey, Petromyzon marinus. J Mol Endocrinol36 601 610 . - 104.
Skinner D. C. Albertson A. J. Navratil A. Smith A. Mignot M. Talbott H. Scanlan-Blake N. 2009 Effects of gonadotrophin-releasing hormone outside the hypothalamic-pituitary-reproductive axis. Journal of Neuroendocrinology21 282 292 . - 105.
Sower S. A. Chiang Y. C. Lovas S. Conlon J. M. 1993 Primary structure and biological activity of a third gonadotropin-releasing hormone from lamprey brain. Endocrinology132 1125 1131 . - 106.
Spies H. G. Norman R. L. Quadri S. K. Clifton D. K. 1977 Effects of estradiol-17beta on the induction of gonadotropin release by electrical stimulation of the hypothalamus in rhesus monkeys. Endocrinology100 314 324 . - 107.
Stevenson T. J. Bentley G. E. Ubuka T. Arckens L. Hampson E. Mac S. A. Dougall-Shackleton 2008 Effects of social cues on GnRH-I, GnRH-II, and reproductive physiology in female house sparrows (Passer domesticus). Gen Comp Endocrinol156 385 394 . - 108.
Stewart A. J. Katz A. A. Millar R. P. Morgan K. 2009 Retention and silencing of prepro-GnRH-II and type II GnRH receptor genes in mammals. Neuroendocrinology90 416 432 . - 109.
Temple J. L. Millar R. P. Rissman E. F. 2003 An evolutionarily conserved form of gonadotropin-releasing hormone coordinates energy and reproductive behavior. Endocrinology144 13 19 . - 110.
Tostivint, 2011 2011. Evolution of the gonadotropin-releasing hormone (GnRH) gene family in relation to vertebrate tetraploidizations. Gen Comp Endocrinol170 575 581 . - 111.
Tsutsumi M. Zhou W. Millar R. P. Mellon P. L. Roberts J. L. Flanagan C. A. Dong K. Gillo B. Sealfon S. C. 1992 Cloning and functional expression of a mouse gonadotropin-releasing hormone receptor. Molecular Endocrinology Baltimore, Md6 1163 1169 . - 112.
Urbanski H. F. White R. B. Fernald R. D. Kohama S. G. Garyfallou V. T. Densmore V. S. 1999 Regional expression of mRNA encoding a second form of gonadotropin-releasing hormone in the macaque brain. Endocrinology140 1945 1948 . - 113.
Vizcarra J. A. Wettemann R. P. Braden T. D. Turzillo A. M. Nett T. M. 1997 Effect of gonadotropin-releasing hormone (GnRH) pulse frequency on serum and pituitary concentrations of luteinizing hormone and follicle-stimulating hormone, GnRH receptors, and messenger ribonucleic acid for gonadotropin subunits in cows. Endocrinology138 594 601 . - 114.
Vizcarra J. Rhoads M. Hsu C. Washington J. Morgan J. Yang J. Tang H. Warren J. Kirby J. 2000 Effect of immunization against chicken gonadotropin releasing hormone-I (cGnRH-I) and cGnRH-II on reproductive function in adult broiler breeder males. Poultry Sci 79: Abs 343. - 115.
Vizcarra J. A. Kreider D. L. Kirby J. D. 2004 Episodic gonadotropin secretion in the mature fowl: serial blood sampling from unrestrained male broiler breeders (Gallus domesticus). Biology of Reproduction70 1798 1805 . - 116.
Vizcarra J. A. Karges S. L. Wettemann R. P. 2012 Immunization of beef heifers against gonadotropin-releasing hormone prevents luteal activity and pregnancy: effect of conjugation to different proteins and effectiveness of adjuvants. Journal of Animal Science (In Press). - 117.
Wade, 1978 1978. Guillemin and Schally: The Years in the Wilderness. Science200 279 282 . - 118.
Weesner G. D. Matteri R. L. 1994 Rapid communication: nucleotide sequence of luteinizing hormone-releasing hormone (LHRH) receptor cDNA in the pig pituitary. Journal of Animal Science 72: 1911. - 119.
Wilson S. C. Sharp P. J. 1975 Episodic release of luteinizing hormone in the domestic fowl. J Endocrinol64 77 86 . - 120.
Wise T. Zanella E. L. Lunstra D. D. Ford J. J. 2000 Relationships of gonadotropins, testosterone, and cortisol in response to GnRH and GnRH antagonist in boars selected for high and low follicle-stimulating hormone levels. Journal of Animal Science78 1577 1590 . - 121.
Yahalom D. Chen A. Ben-Aroya N. Rahimipour S. Kaganovsky E. Okon E. Fridkin M. Koch Y. 1999 The gonadotropin-releasing hormone family of neuropeptides in the brain of human, bovine and rat: identification of a third isoform. FEBS Lett463 289 294 . - 122.
Yu W. H. Karanth S. Walczewska A. Sower S. A. Mc Cann S. M. 1997 A hypothalamic follicle-stimulating hormone-releasing decapeptide in the rat. Proceedings of the National Academy of Sciences of the United States of America94 9499 9503 . - 123.
Yu W. H. Karanth S. Sower S. A. Parlow A. F. Mc Cann S. M. 2000 The similarity of FSH-releasing factor to lamprey gonadotropin-releasing hormone III (l-GnRH-III). Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine New York, N.Y224 87 92 . - 124.
Yu W. H. Karanth S. Mastronardi C. A. Sealfon S. Dean C. Dees W. L. Mc Cann S. M. 2002 Lamprey GnRH-III acts on its putative receptor via nitric oxide to release follicle-stimulating hormone specifically. Experimental Biology and Medicine Maywood, N.J227 786 793 . - 125.
Zanella E. L. Lunstra D. D. Wise T. H. Kinder J. E. Ford J. J. 2000 GnRH antagonist inhibition of gonadotropin and steroid secretion in boars in vivo and steroid production in vitro. Journal of Animal Science78 1591 1597 . - 126.
Ziecik A. J. Esbenshade K. L. Britt J. H. 1989 Effects of a gonadotrophin-releasing hormone antagonist on gonadotrophin secretion and gonadal development in neonatal pigs. J Reprod Fertil87 281 289 .